COVID‑19 Alert: Stay home if you feel unwell. If you have a fever, cough and difficulty breathing, seek medical attention. Follow the directions of your local health authority. Source WHO

We have a lockdown, "Working from HOME" Please reach out for any queries at: help@alliedmarketresearch.com & Int'l : +1-503-894-6022, (UK) : +44-845-528-1300

Global Biochips Market Expected to Reach $ 21,419 Million by 2025


quote Biochips have garnered a substantial share in the recent years, due to large number of applications across the life science field, increase in prevalence of cancer, and high preference for biochip products. Development of advanced biochips with improved features has led to widening of applications of these products, thereby supplementing the market growth. Furthermore, increase in strategic developments by key players is anticipated to fuel the market growth in the near future. quote

Onkar Sumant
Assistant Manager, Healthcare Research at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       

According to a new report published by Allied Market Research, titled, Biochips Market, by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 20182025," the market was valued at $9,037 million in 2017, and is projected to reach $21,419 million by 2025, registering a CAGR of 11.2% from 2018 to 2025.

Biochip is a miniaturized integrated medical device, which performs numerous biological or biochemical reactions simultaneously. It is extremely small in size, and consists of microscope slide, which is manufactured of glass, nylon, or silicon. It is a collection of microarrays, which are arranged on a solid substrate and perform functions such as decoding genes, screening of large number of biological analytes, and finding contaminations in a few seconds.

The biochips market is anticipated to exhibit significant growth in the near future, owing to factors such as rise in prevalence of life-threatening disorders, surge in number of aged people who are susceptible to cancer, increase in applications of biochips, and high demand for personalized medicines. However, high cost of biochip products and lack of knowledge about biochips hinder the market growth. On the contrary, increase in R&D investments as well as government funding and high growth potential in developing regions are expected to provide numerous opportunities for the market growth.

The DNA chip segment accounted for the largest share in 2017, owing to high availability of DNA chips as compared to other products. However, the protein chip segment is expected to grow at the high CAGR from 2018 to 2025.

The drug discovery & development segment led the global biochips market in 2017, and is expected to maintain this trend during the forecast period. On the other hand, disease diagnostics segment is anticipated to record the highest CAGR from 2018 to 2025.

The utilization rate of biochips in biotechnology and pharmaceutical companies was high in 2017. However, the academic and research institutes segment is expected to grow at a CAGR of 13.5% during the forecast period.

Key findings of the Biochips Market :

  • The lab-on-a-chip segment accounted for nearly 37% share of the global biochips market in 2017.

  • The genomics segment is expected to grow at a CAGR of 10.6% from 2018 to 2025.

  • The hospitals & diagnostics centers segment accounted for around one-fourth share of the global market in 2017.

  • Europe accounted for more than one-fourth share of the global market in 2017.

  • LAMEA is expected to grow at a CAGR of 11.9% from 2018 to 2025.

North America accounted for more than 40% share of the global market in 2017, and is expected to remain dominant throughout the forecast period. This is attributed to increase in incidence of cancer, growth in geriatric population, and adoption of biochips due to their wide applications. In addition, presence of high number of key players and availability of sophisticated healthcare infrastructure are expected to offer new growth opportunities to the market players in future.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com


For Media Inquiries, Please Contact

Ram D
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at


First time buyer?
Check offers and discount on this report
To get this report

Click Here

quote Biochips Market by Product (DNA Chip, Protein Chip, Lab-on-a-chip, and Others), Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, and Others), and End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025 quote

View Report

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers


Featured Readings


Get Fresh content delivered

Get insights on topics that matter to your business. Stay updated on the area that interests you.

Get Industry Data Alerts

Buy Full Version
"Global Biochips Market"
Purchase Enquiry